Next-generation vaccine development

Ziphius Vaccines addresses urgent global public health needs by developing 

RNA-based vaccines, providing a more robust immune response than traditional vaccines.

ZIP-1642

Ziphius' vaccine candidate

against COVID-19

Latest news

December 21, 2020

COVID-19 update

Promising results have been obtained, driving us forward to prepare for clinical trials

OUR TECHNOLOGY

Ziphius uses its proprietary self-amplifying RNA-platform for the development of next-generation vaccines. 

OUR PIPELINE

We are dedicated to leverage our technology for the prevention of a broad range of infectious diseases. 

Find out more...

ABOUT US

Ziphius Vaccines is a global biopharmaceutical company that wants to make the difference by accelerating the development of novel therapies.

CAREER OPPORTUNITIES

Whether you are looking for a new challenge, an internship, or your first job, 
we are looking forward to connecting with you. 

NEWSROOM

Curious for more? Browse this page to find out about our latest news, including research updates, press releases, and upcoming events.

 Address. Legeweg 157C,  B-8020 Oostkamp, Belgium

© 2019 Ziphius Vaccines NV